Fisher-Price High Chair Recall Issued After Child Suffers Skull Fracture

About 24,000 Fisher-Price 3-in-1 high chairs have been recalled due to a defective design of the booster seat release, which could cause the seat back to detach or fall backwards, posing a potential fall hazard.

At least one report of problems with the Fisher-Price high chair seat back has been received, involving a young child who suffered a skull fracture in a fall.

The defective Fisher-Price high chairs were sold exclusively at Target stores between December 2008 and March 2009 for about $100.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The product was marketed as a Fisher-Price “3-in-1 High Chair to Booster,” which contains a removable tray, adjustable seat and converts from a high chair to a booster seat.

The high chair recall applies to units that have the product number P5369 printed on the side of the seat, on a label on the seat pad and on the high chair’s packaging.

There are two main defects in the product. The first involves the booster seat release becoming unlatched while the child is in the chair, causing the seat to fall backwards. The second involves the seatback detaching if it is not fully snapped into place. Both of these problems may cause the child to fall out of the high chair and cause injuries that could be serious.

 
Parents have been urged to stop using the Fisher-Price high chairs and to contact the manufacturer at (800) 432-5437 to request a free repair kit and instructions. Additional information can also be obtained at www.service.mattel.com.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted 2 days ago)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 4 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.